Abbreviations:
respiratory syndrome coronavirus 2JX and JS, coronavirus disease
EMERGENCY
coronavirus disease 2019Nirmatrelvir plus ritonavirsevere acute respiratory syndrome coronavirus 2JX and JS contributed equally to this work.This study was approved by the Institutional Review Board of the People Hospital of Shijiazhuang (No. 2023008) and conducted in accordance with the ethical principles for medical research involving human subjects established in the Helsinki Declaration, protecting the privacy and confidentiality of personal information of all participants. This study was registered with The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.The authors have no conflicts of interest to disclose.This work was supported by National Key Research and Development Program of China (2021YFC0863200), National Administration of Traditional Chinese Medicine Emergency Special Project on Traditional Chinese Medicine for COVID-19 (2022ZYLCYJ02-1), Hebei Provincial Key Research and Development Project (20277709D), and Scientific and Technological Research and Development Plan of Shijiazhuang city (201460463A).How to cite this article: Xu J, Song J, Xie Z, Yang J, Wu D, Liu F, Zhao Y, Zang H, Zhao Y. Impact of Paxlovid on in-hospital outcomes and post-COVID-19 condition in adult patients infected with SARS-CoV-2 Omicron variant: A non-randomized controlled clinical trial. Medicine 2023;102:51(e36714).